MENU NAVIGATION Argonne National Laboratory SEARCH SEARCH ARGONNE NATIONAL LABORATORY COVID-19 Research Argonne scientists and research facilities help track, treat and stop the spread of the global pandemic. SHARE Facebook Twitter LinkedIn Email Scientists at the U.S. Department of Energy’s Argonne National Laboratory joined the global fight against the COVID-19 pandemic in January 2020, as the disease was just beginning to reach the United States. Since then, Argonne’s researchers and powerful scientific facilities have made a difference in the fight against COVID-19 in many different areas, from laying the groundwork for vaccines, to forecasting virus spread, to manufacturing better masks. Researchers from across the country use the ultra-bright, high-energy X-rays provided by Argonne’s Advanced Photon Source to determine the protein structures of the virus, making COVID-19 vaccines more effective and advancing the development of treatments. Argonne couples state-of-the-art supercomputing and artificial intelligence to rapidly screen billions of potential drug molecules by simulating how they interact with viral proteins. We support City of Chicago, State of Illinois, and federal officials by modeling the spread of COVID-19 and the effectiveness of preventative measures, and by ensuring that supply chains and key infrastructure remain resilient in a time of uncertainty. Researchers from Argonne, industry and academia use our specialized facilities to develop reusable, anti-viral N95 mask filters and determine the effectiveness of fabrics for homemade masks. Argonne is part of the U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL), a consortium of DOE national laboratories with core capabilities relevant to the threats posed by COVID-19, and the COVID-19 High Performance Computing Consortium that combines the power of 16 different supercomputing systems with expertise from government, academia, and industry. Our research and our scientific facilities are helping the nation overcome the COVID-19 crisis. The stories linked from this site provide the latest COVID-19 research updates from Argonne and from media outlets. COVID-19 RESEARCH NEWS Using the Advanced Photon Source, researchers advance battle against COVID-19 November 18, 2021 PRESS RELEASE Argonne accelerates COVID antiviral discovery with AI Search time for usable antiviral candidates reduced from years to minutes. November 17, 2021 | Computational Science, Biomedical Computing, Computational Biology AWARDS AND RECOGNITION Waltzing the virus: Study on COVID-19 reproduction earns Argonne researchers Gordon Bell Special Prize nomination Argonne scientists part of team nominated for supercomputing prize. November 16, 2021 | Computational Science, Medical Science, Diseases PRESS RELEASE Advanced Photon Source helps Pfizer create COVID-19 antiviral treatment The new drug candidate, Paxlovid, significantly reduced hospitalization and death in adult patients, according to Pfizer, and will be submitted for an emergency use authorization in the United States. November 05, 2021 | Diseases, COVID-19, Coronavirus Argonne collaborations bring computational tools to the forefront of COVID-19 research August 31, 2021 Antonopoulos answers questions about variants and vaccines in Foster’s online panel August 27, 2021 Existing drug is shown to inhibit virus that causes COVID-19 August 02, 2021 AWARDS AND RECOGNITION Argonne’s Macal named Fellow of the Society for Computer Simulation International Charles M. “Chick” Macal, a modeling and simulation expert at Argonne, garnered the distinguished title of Fellow of the Society for Computer Simulation International for his 20 years in the field and his recent studies on COVID-19 spread. July 29, 2021 | Modeling and Simulation, COVID-19, Coronavirus Scientists repurpose cancer and seizure medications to aid in the fight against COVID-19 July 12, 2021 PRESS RELEASE For the first time, Argonne researchers reveal how COVID-19 has transformed communities Argonne researchers have launched new map-based tools that show how communities held up as COVID-19 spread. May 12, 2021 | Data Science/Data Analysis, Emergency Management, COVID-19 TAGS: Diseases, Modeling And Simulation, Protein Science, Structural Biology, X-Ray Science And Technology, COVID-19, Coronavirus CONTACT US For More Information or Media Related Inquiries +1-630-252-5580 media@anl.gov CONTACT US To discuss a potential research partnership with Argonne or to enquire about licensing Argonne technology +1-800-627-2596 partners@anl.gov RELATED ORGANIZATIONS Advanced Photon Source Argonne Leadership Computing Facility Computing, Environment and Life Sciences Decision and Infrastructure Sciences Energy and Global Security Photon Sciences ARGONNE COVID-19 RESEARCH IN THE NEWS How to COVID-proof the grocery line, classroom, and orchestra November 10, 2021 Due to research done at Chicago-area’s Argonne National Laboratory, Pfizer has been able to develop a new anti-viral COVID-19 treatment November 09, 2021 | COVID-19, Coronavirus Chicago lab tracks COVID-19 through wastewater October 15, 2021 | COVID-19, Coronavirus COVID-19 vaccine effectiveness barely affected by Delta variant, research suggests September 27, 2021 | COVID-19, Coronavirus The COVID conundrum: Regional school boards getting an earful as the pandemic continues August 23, 2021 | Coronavirus, COVID-19 First-Ever Data4All Workshop Nurtures Future Data Scientists From Chicago’s South Side June 17, 2021 How These 2 Tech Stocks Are Helping the Fight Against COVID-19 May 18, 2021 COVID Search and Destroy: Scientists Design “Nanotraps” to Catch and Clear Coronavirus From Tissue May 10, 2021 | COVID-19, immunology, infectious diseases UChicago scientists design ‘nanotraps’ to catch and clear coronavirus from tissue April 27, 2021 | nanoparticles, COVID-19, Coronavirus Nanotrap Developed By University Of Chicago Researchers Could Be Breakthrough COVID-19 Treatment April 27, 2021 | COVID-19, Coronavirus, SARS-CoV-2 COVID-19 vaccines administered in Chicago workplaces: A long shot? April 26, 2021 There may finally be enough COVID-19 vaccine for employers to offer shots at work. These companies are making plans. April 23, 2021 Cerebras’ New Monster AI Chip Adds 1.4 Trillion Transistors April 20, 2021 Landmark discovery may lead to safe, effective antiviral drugs against COVID-19 April 08, 2021 R&D on today’s coronavirus vaccines started in 2013 April 01, 2021 Argonne National Laboratory 9700 S. Cass Avenue Lemont, IL 60439 +1-630-252-2000 Twitter Flickr Facebook LinkedIn YouTube Instagram Footer menu CONNECT WITH US Tour the Laboratory Attend an OutLoud Lecture Subscribe to Argonne Find an Argonne Researcher Contact Us CONDUCT RESEARCH WITH US Apply to Use Our User Facilities Collaborate with Our Centers, Institutes and Programs Become a Lab Technologist Conduct Thesis Research Apply for a Postdoc Appointment PARTNER WITH US Secure Our Nation Increase Manufacturing Competitiveness Unlock Energy Storage Potential Develop or License Technologies Gain Entrepreneurial Support NEWSROOM Argonne Advances Feature Stories In the News Press Releases Media Contacts U.S. Department of Energy Office of Science Privacy & Security Notice For Employees Site Feedback